Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

Once reserved for the fittest, worldwide altitude travel has become increasingly accessible
for ageing and less fit people. As a result, more and more individuals with varying degrees of …

Erratum: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension:
Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the …

Question addressed by the study To investigate exercise performance and hypoxia-related
health effects in patients with pulmonary hypertension (PH) during a high-altitude sojourn …

Methods Pulmonary vascular disease patients were investigated at 470 m (Zurich, low
altitude, LA) and 2500 m (high altitude, HA) during a 30 h overnight stay at Mount Säntis …

Prediction of adverse health effects at altitude or during air travel is relevant, particularly in
pre-existing cardiopulmonary disease such as pulmonary arterial or chronic thromboembolic …

Ulrich, Silvia, Mona Lichtblau, Simon R. Schneider, Stéphanie Saxer, and Konrad E. Bloch,
Clinician's corner: counseling patients with pulmonary vascular disease traveling to high …

Pulmonary arterial hypertension (PAH) is a rare and progressive disease characterised by
remodelling of the pulmonary arteries and progressive narrowing of the pulmonary …

Over 80 Mio people worldwide live> 2500 m, including at least as many patients with
pulmonary vascular disease (PVD), defined as pulmonary arterial or chronic …

Pulmonary vascular diseases (PVDs), defined as arterial or chronic thromboembolic
pulmonary hypertension, are associated with autonomic cardiovascular dysregulation …